Prospective acetylcholinesterase inhibitory activity of indole and its analogs

Bioorganic and Medicinal Chemistry Letters

Volumn 22, Issue 8, 2012, Pages 2885-2888

  Khorana, Nantaka ^a   Changwichit, Kanokwan ^a   Ingkaninan, Kornkanok ^a   Utsintong, Maleeruk ^b  

^a NARESUAN UNIVERSITY   (Thailand)

^b UNIVERSITY OF PHAYAO   (Thailand)

Author keywords

Carbolines; Acetylcholinesterase inhibitory activity; Alzheimer's disease; Indoles; Quinolines

Indexed keywords

BETA CARBOLINE DERIVATIVE; CHOLINESTERASE INHIBITOR; GALANTAMINE; INDOLE; INDOLE DERIVATIVE; QUINOLINE DERIVATIVE; SEROTONIN;

ARTICLE; CHEMICAL MODIFICATION; DRUG BINDING SITE; DRUG CONFORMATION; ENZYME INHIBITION; MOLECULAR DOCKING;

ACETYLCHOLINESTERASE; BINDING SITES; CARBOLINES; CHOLINESTERASE INHIBITORS; ENZYME ACTIVATION; HUMANS; INDOLES; MOLECULAR CONFORMATION; QUINOLINES;

EID: 84859437958     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.02.057     Document Type: Article

References (17)

1. I.S. Johnson, J.G. Armstrong, M. Gorman, and J.P. Burnett Jr. Cancer Res. 23 1963 1390
2. H. Takayama Chem. Pharm. Bull. 52 2004 916
3. W.M. Welch, C.A. Harbert, and A. Weissman J. Med. Chem. 23 1980 704
4. M.A. Mroue, K.L. Euler, M.A. Ghuman, and M. Alam J. Nat. Prod. 59 1996 890
5. M.T. Andrade, J.A. Lima, A.C. Pinto, C.M. Rezende, M.P. Carvalho, and R.A. Epifanio Bioorg. Med. Chem. 13 2005 4092
6. K. Ingkaninan, K. Changwijit, and K. Suwanborirux J. Pharm. Pharmacol. 58 2006 847
7. Z.-J. Zhan, Q. Yu, Z.-L. Wang, and W.-G. Shan Bioorg. Med. Chem. 20 2010 6185
8. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, and H.M. Arrighi Alzheimers Dement. 3 2007 186
9. The AChE in this assay was from electric eel (type VI-S, sigma). Briefly, 125 μL of 3 mM DTNB, 25 μL of 1.5 mM ATCI, 50 μL of 50 mM Tris-HCl buffer (pH 8.0) and 25 μL of sample dissolved in buffer containing not more than 10% MeOH were added to the wells followed by 25 μL of 0.28 U/mL AChE. The microplate was read at 405 nm every 5 s for 2 min using microplate reader. Every experiment was done in triplicate.
10. L.G. Ellman, K.D. Courtney, V. Andres Jr., and M.R. Featherstone Biochem. Pharmacol. 2 1961 88
11. K. Ingkaninan, P. Temkitthawon, K. Chuenchom, T. Yuyaem, and W. Thongnoi J. Ethanopharmacol. 89 2003 261
12. H. Hayashi, Y. Miwa, I. Miki, S. Ichikawa, N. Yoda, A. Ishii, M. Kono, and F. Suzuki J. Med. Chem. 35 1992 4893
13. S. Markmee, S. Ruchirawat, V. Prachyawarakorn, K. Ingkaninan, and N. Khorana Bioorg. Med. Chem. Lett. 16 2006 2170
14. N. Khorana, S. Markmee, K. Ingkaninan, S. Ruchirawat, R. Kitbunnadaj, and M.R. Pullagurla Med. Chem. Res. 18 2009 231
15. human-AChE inhibitory activity was performed similar procedure to eel-AChE inhibitory activity by changing the enzyme to human recombinant AChE.
16. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.W. Hart, R.K. Belew, and A.J. Olson J. Comp. Chem. 19 1998 1639
17. M.F. Sanner J. Mol. Graph. Mod. 17 1999 57